{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:51:27Z","timestamp":1791204687857,"version":"4.2.0"},"reference-count":65,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS) places substantial socioeconomic burden on patients due to its early onset and progressive nature, but healthcare systems are also impacted by the high costs of disease\u2010modifying treatments (DMTs). The use of generics (for conventional drugs), biosimilars (for biologics) or follow\u2010on versions of non\u2010biologic complex drugs (NBCDs) can help to reduce the cost of MS care and improve patient access. This review describes the European regulatory processes for these DMT \u2018copies\u2019 and the available data in people with MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A PubMed literature search was undertaken in March 2024, using the terms \u2018biosimilar\u2019, \u2018generic\u2019, \u2018non\u2010biologic complex drug\u2019, \u2018NBCD\u2019 and \u2018follow\u2010on\u2019 in association with \u2018multiple sclerosis\u2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our literature search identified three clinical studies with generic treatments for MS (two with generic fingolimod and one with generic dimethyl fumarate), 11 studies with biosimilars (eight with biosimilar interferon formulations, one with natalizumab and two with rituximab biosimilars) and six studies with follow\u2010on glatiramer acetate. The data showed that the generics, biosimilars and follow\u2010on NBCDs had similar clinical efficacy and tolerability profiles to the originator drugs, although the quality and quantity of the research varied between DMTs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In Europe, there are robust regulatory processes for generics, biosimilars and follow\u2010on NBCDs, in order to ensure that these agents can be considered equally effective and safe as the originator DMT. Physicians caring for people with MS should familiarise themselves with the evidence so that they can have informed conversations about the potential use of these agents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ene.70140","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T08:03:39Z","timestamp":1744704219000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Generics, Biosimilars and Follow\u2010On Non\u2010Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists"],"prefix":"10.1111","volume":"32","author":[{"given":"Thomas","family":"Berger","sequence":"first","affiliation":[{"name":"Department of Neurology and Comprehensive Center for Clinical Neurosciences and Mental Health Medical University of Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zeitlinger","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology Medical University of Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Popescu","sequence":"additional","affiliation":[{"name":"University MS Center, Hasselt\u2010Pelt Noorderhart Hospital  Belgium"},{"name":"Hasselt University  Hasselt Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Magyari","sequence":"additional","affiliation":[{"name":"Danish Multiple Sclerosis Center  Glostrup Denmark"},{"name":"Copenhagen University Hospital Rigshospitalet  Copenhagen Denmark"},{"name":"The Danish Multiple Sclerosis Registry, Department of Neurology Copenhagen University Hospital\u2014Rigshospitalet  Glostrup Denmark"},{"name":"Institute for Clinical Medicine University of Copenhagen  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Airas","sequence":"additional","affiliation":[{"name":"University of Turku  Turku Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Alkhawajah","sequence":"additional","affiliation":[{"name":"Neuroimmunology Integrated Practice Unit, Neuroscience Center King Faisal Specialist Hospital and Research Centre  Riyadh Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9396-8683","authenticated-orcid":false,"given":"Maura","family":"Pugliatti","sequence":"additional","affiliation":[{"name":"University of Ferrara  Ferrara Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magd","family":"Zakaria","sequence":"additional","affiliation":[{"name":"Ain\u2010Shams University  Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6360-4798","authenticated-orcid":false,"given":"Carlo","family":"Pozzilli","sequence":"additional","affiliation":[{"name":"University of Roma La Sapienza  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4516-3458","authenticated-orcid":false,"given":"Jelena","family":"Drulovic","sequence":"additional","affiliation":[{"name":"University of Belgrade  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Van Wijmeersch","sequence":"additional","affiliation":[{"name":"University MS Center, Hasselt\u2010Pelt Noorderhart Hospital  Belgium"},{"name":"Hasselt University  Hasselt Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Vermersch","sequence":"additional","affiliation":[{"name":"University of Lille, Inserm U1172, Lille Neuroscience &amp; Cognition Research Centre (LilNCog), CHU Lille, FHU Precise  Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-5716","authenticated-orcid":false,"given":"Celia","family":"Oreja\u2010Guevara","sequence":"additional","affiliation":[{"name":"Department of Neurology Hospital Cl\u00ednico San Carlos, IdISSC  Madrid Spain"},{"name":"Department of Medicine Complutense University of Madrid  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01473-3"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-12047-9"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-329049"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104103"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517694432"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-022-01547-6"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00556-y"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913\u2010022\u201008883\u20106"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0566-3"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-019-0145-0"},{"key":"e_1_2_11_12_1","unstructured":"European Medicines Agency \u201cGeneric Medicine \u201d accessed March 5 2024 https:\/\/www.ema.europa.eu\/en\/glossary\/generic\u2010medicine#:~:text=A%20generic%20medicine%20is%20a studies%20on%20the%20authorised%20medicine."},{"key":"e_1_2_11_13_1","unstructured":"U.S. Food and Drug Administration \u201cGeneric Drugs: Questions & Answers \u201d accessed February 22 2024 https:\/\/www.fda.gov\/drugs\/frequently\u2010asked\u2010questions\u2010popular\u2010topics\/generic\u2010drugs\u2010questions\u2010answers."},{"key":"e_1_2_11_14_1","unstructured":"European Medicines Agency \u201cBiosimilars in the EU: Information Guide for Healthcare Professionals \u201d accessed February 22 2024 https:\/\/www.ema.europa.eu\/system\/files\/documents\/leaflet\/biosimilars\u2010eu\u2010information\u2010guide\u2010healthcare\u2010professionals_en_1.pdf."},{"key":"e_1_2_11_15_1","first-page":"1","article-title":"Non\u2010biologic Complex Drugs: Glatiramoide in der Therapie der Multiplen Sklerose","volume":"3","author":"Berger T.","year":"2016","journal-title":"Neurologische"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.590527"},{"key":"e_1_2_11_17_1","first-page":"26","article-title":"How Generic Drugs Are Made","volume":"38","author":"Pierini D.","year":"2013","journal-title":"US Pharmacist"},{"key":"e_1_2_11_18_1","unstructured":"European Medicines Agency \u201cGuideline on the Investigation of Bioequivalence \u201d accessed April 2 2024 https:\/\/www.ema.europa.eu\/en\/documents\/scientific\u2010guideline\/guideline\u2010investigation\u2010bioequivalence\u2010rev1_en.pdf."},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijnpnd.ijnpnd_96_20"},{"key":"e_1_2_11_20_1","first-page":"698","article-title":"Biosimilar Monoclonal Antibodies: Preclinical and Clinical Development Aspects","volume":"34","author":"Gon\u00e7alves J.","year":"2016","journal-title":"Clinical and Experimental Rheumatology"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281562"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2017.1305530"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.03.029"},{"key":"e_1_2_11_24_1","unstructured":"European Medicines Agency \u201cReflection Paper on the Data Requirements for Intravenous Iron\u2010Based Nano\u2010Colloidal Products Developed With Reference to an Innovator Medicinal Product \u201d accessed February 22 2024 https:\/\/www.ema.europa.eu\/en\/documents\/scientific\u2010guideline\/reflection\u2010paper\u2010data\u2010requirements\u2010intravenous\u2010iron\u2010based\u2010nano\u2010colloidal\u2010products\u2010developed\u2010reference\u2010innovator\u2010medicinal\u2010product_en.pdf."},{"key":"e_1_2_11_25_1","unstructured":"European Medicines AgencyandAdministration USFaD \u201cPilot program: EMA\u2010FDA Parallel Scientific Advice for Hybrid\/Complex Generic Products\u2014General Principles \u201d accessed April 2 2024 https:\/\/www.fda.gov\/media\/152085\/download."},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12154937"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104880"},{"key":"e_1_2_11_28_1","first-page":"23","article-title":"Clinical and Demographic Characteristics and Two\u2010Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients With Fingolimod Treatment","volume":"60","author":"Terzi M.","year":"2023","journal-title":"Noro Psikiyatri Arsivi"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105760"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/786526"},{"key":"e_1_2_11_31_1","first-page":"39","article-title":"Experience of Using Genfaxon for Treating Patients With Relapsing\u2013Remitting Multiple Sclerosis in The Russian Federation","volume":"114","author":"Bakhtiiarova K. Z.","year":"2014","journal-title":"Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20191192273"},{"key":"e_1_2_11_33_1","first-page":"113","article-title":"Biosimilar of interferon\u2010beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal","volume":"112","author":"Khabirov F. A.","year":"2012","journal-title":"Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20181183118-26"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2012.02.039"},{"key":"e_1_2_11_36_1","first-page":"93","article-title":"The First Experience of the Use the Russian Beta\u2010Interferon\u20101b Biosimilar (Infibeta) in the Daily Practice of the Moscow Center of Multiple Sclerosis","volume":"113","author":"Popova E. V.","year":"2013","journal-title":"Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2012.11.013"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.5007"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.101419"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520912170"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.2154"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201611610261-67"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20161166173\u201075"},{"key":"e_1_2_11_44_1","unstructured":"European Medicines Agency \u201cDrugs Approved for Multiple Sclerosis.\u201d accessed 15 July 2024 https:\/\/www.ema.europa.eu\/en\/search?search_api_fulltext=multiple%20sclerosis&f%5B0%5D=ema_search_custom_entity_bundle%3Aother&page=1."},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756285614563522"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2018.05.001"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1929135"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201811812125"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2020.1760808"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008936"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2019.102243"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1571296"},{"key":"e_1_2_11_53_1","first-page":"240","article-title":"Knowledge, perceptions, attitude, barriers and facilitators of biosimilars use across specialty physicians and hospital pharmacists: a national survey","volume":"45","author":"Mar\u00edn\u2010Jim\u00e9nez I.","year":"2021","journal-title":"Farmacia Hospitalaria"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034183"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1177\/13524585221116269"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.03.014"},{"key":"e_1_2_11_57_1","unstructured":"European Medicines Agency \u201cStatement on the Scientific Rationale Supporting Interchangeability of Biosimilar Medicine in the EU \u201d accessed April 3 2024 https:\/\/www.ema.europa.eu\/en\/documents\/public\u2010statement\/statement\u2010scientific\u2010rationale\u2010supporting\u2010interchangeability\u2010biosimilar\u2010medicines\u2010eu_en.pdf."},{"key":"e_1_2_11_58_1","first-page":"311","article-title":"Adherence to Treatment of Multiple Sclerosis in a Health Care Program","volume":"81","author":"Zanga G.","year":"2021","journal-title":"Medicina (B Aires)"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.14211"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-014287"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2021.03.200361"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-019-0139-y"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517739976"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2021.27.8.1129"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0431-5"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1610381"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ene.70140","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ene.70140","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ene.70140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:58:13Z","timestamp":1791201493000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ene.70140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1111\/ene.70140"],"URL":"https:\/\/doi.org\/10.1111\/ene.70140","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-09-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70140"}}